Why Retatrutide Isn't Right For Me + NHS's New Mounjaro (Zepbound) Plan

Why Retatrutide Isn't Right For Me + NHS's New Mounjaro (Zepbound) Plan

July 10, 2026 · 12 min · Season 44 · Episode 1

About this episode

The episode discusses the NHS's new Mounjaro plan and reasons for rejecting Retatrutide.

⚖️ Renpho Morphoscan Base Scale — https://lvnta.com/lv_JdHgSA7agu8wJ8Q3yaThe NHS is about to completely bypass your GP for Mounjaro (Zepbound) + Why I said no to Retatrutide. This is a massive milestone for the Mounjaro UK community. A brand-new £85m pilot is launching across 12 areas, offering direct self-referral access to tirzepatide without a GP appointment. Plus, an FDA warning every GLP-1 user needs to hear — over 1,700 adverse events linked to fake and compounded semaglutide, many resulting in hospitalisation.This week's stories:🏥 NHS bypasses GPs — the £85m OPIP pilot explained🏋️ Jabs, gyms & smartphones — what the pilot actually includes⚠️ FDA fake GLP-1 warning — 1,700+ adverse events reported📊 GPs at breaking point — 1 in 25 consultations now Mounjaro-related Check out all the update videos on YouTube:👇 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube Weekly Videos⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ *The episodes in this series are recorded as YouTube videos; there will be references to things on screen at times if you are listening only.

More episodes of Phill Double L: Mounjaro Weight Loss & GLP-1 Journey

Explore listener stats, chart rankings, contacts and more on the Phill Double L: Mounjaro Weight Loss & GLP-1 Journey podcast page.